Cargando…
Translating MSC Therapy in the Age of Obesity
Mesenchymal stromal cell (MSC) therapy has seen increased attention as a possible option to treat a number of inflammatory conditions including COVID-19 acute respiratory distress syndrome (ARDS). As rates of obesity and metabolic disease continue to rise worldwide, increasing proportions of patient...
Autores principales: | Boland, Lauren, Bitterlich, Laura Melanie, Hogan, Andrew E., Ankrum, James A., English, Karen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289617/ https://www.ncbi.nlm.nih.gov/pubmed/35860241 http://dx.doi.org/10.3389/fimmu.2022.943333 |
Ejemplares similares
-
Improved MSC Minimal Criteria to Maximize Patient Safety: A Call to Embrace Tissue Factor and Hemocompatibility Assessment of MSC Products
por: Moll, Guido, et al.
Publicado: (2022) -
Efferocytosis of viable versus heat-inactivated MSC induces human monocytes to distinct immunosuppressive phenotypes
por: Schrodt, Michael V., et al.
Publicado: (2023) -
Aggregation of Human Mesenchymal Stromal Cells Eliminates Their Ability to Suppress Human T Cells
por: Burand, Anthony J., et al.
Publicado: (2020) -
Editorial: Safety, Efficacy and Mechanisms of Action of Mesenchymal Stem Cell Therapies
por: Moll, Guido, et al.
Publicado: (2020) -
Cell-free DNA measurement of three genomes after allogeneic MSC therapy in kidney transplant recipients indicates early cell death of infused MSC
por: Dreyer, Geertje J., et al.
Publicado: (2023)